DOI:
10.1055/s-00000133
Gastroenterologie up2date
LinksClose Window
References
Trent JC, Wathen K, von Mehren M et al.
A phase II study of dasatinib for patients with imatinib-resistant gastrointestinal stromal tumor (GIST).
J Clin Oncol 2011;
29 abstr 10006
Search in:
We do not assume any responsibility for the contents of the web pages of other providers.